Notably, in the HSC-2+PDLCs group, the absolute number of PTHrP(+)AE1/3(+) cells was reduced (Figure 5b), but their proportion among the total cancer cell population increased (Figure 5c), despite a concurrent decline in overall IHC scores (Figure 5e). The gene discussed is PTHLH; the disease is cancer.